Inhaled antibody therapy to protect against new COVID variants
by Press Release from Outbreak News Today on (#5EJJN)
By NewsDesk @bactiman63 Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, announced today that it has augmented its inhaled AR-711 monoclonal antibody (mAb) to COVID-19 with a second mAb (AR-713) that is designed to neutralize newly emerging COVID-19 mutated variants including those from South Africa, Brazil and Japan. Together, [...]
The post Inhaled antibody therapy to protect against new COVID variants appeared first on Outbreak News Today.